-+ 0.00%
-+ 0.00%
-+ 0.00%

Enterprise Development says it halts further lending to Sailong Pharma after RMB 25 million loan

PUBT·08/19/2026 12:56:20
Listen to the news
Enterprise Development says it halts further lending to Sailong Pharma after RMB 25 million loan
  • Enterprise Development Holdings issued a supplemental update on its RMB 100 million loan facility to Sailong Pharmaceutical Group.
  • Sailong’s shares were delisted from the Shenzhen Stock Exchange effective July 17, 2026.
  • Only RMB 25 million has been drawn under the facility; no further lending will be provided.
  • The loan carries 3% annual interest with a 12-month term; interest has been paid monthly to date.
  • The loan was positioned as support to protect its indirect investment; repayment will be monitored, recovery action considered if needed.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enterprise Development Holdings Limited published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260819-12290936), on August 19, 2026, and is solely responsible for the information contained therein.